Raphael E. Pollock

Articles in Scholarly Journals [Incomplete List]

  1. Periosteal margin in soft-tissue sarcoma
    Cancer, vol. 109, no. 3, pp. 598–602, 2007
  2. High prevalence ofp53 exon 4 mutations in soft tissue sarcoma
    Cancer, vol. 109, no. 11, pp. 2323–2333, 2007
  3. Retroperitoneal soft tissue sarcoma: An analysis of radiation and surgical treatment
    International Journal of Radiation OncologyBiologyPhysics, vol. 67, no. 1, pp. 158–163, 2007
  4. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy
    International Journal of Radiation OncologyBiologyPhysics, vol. 67, no. 4, pp. 1124–1129, 2007
  5. Surgical oncology at the crossroads: which way forward?
    The Lancet Oncology, vol. 8, no. 3, pp. 182–183, 2007
  6. Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma
    Gene Therapy, vol. 14, no. 8, Article ID 3302911, 10 pages, 2007
  7. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas
    Proceedings of the National Academy of Sciences, vol. 104, no. 9, pp. 3414–3419, 2007
  8. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation
    Molecular Cancer Therapeutics, vol. 6, no. 5, pp. 1650–1660, 2007
  9. Optimizing Treatment of Desmoid Tumors
    Journal of Clinical Oncology, vol. 25, no. 13, pp. 1785–1791, 2007
  10. Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis
    Annals of Surgical Oncology, vol. 14, no. 8, pp. 2309–2318, 2007
  11. Current concepts in multimodality therapy for retroperitoneal sarcoma
    Expert Review of Anticancer Therapy, vol. 7, no. 2, pp. 159–168, 2007
  12. Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma
    Annals of Surgical Oncology, vol. 13, no. 4, pp. 508–517, 2006
  13. The Effect of Preoperative Radiotherapy and Reconstructive Surgery on Wound Complications after Resection of Extremity Soft-Tissue Sarcomas
    Annals of Surgical Oncology, vol. 13, no. 9, pp. 1209–1215, 2006
  14. Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib
    Annals of Surgical Oncology, vol. 14, no. 1, pp. 14–24, 2006
  15. Wild-type p53 Inhibits Nuclear Factor- B-Induced Matrix Metalloproteinase-9 Promoter Activation: Implications for Soft Tissue Sarcoma Growth and Metastasis
    Molecular Cancer Research, vol. 4, no. 11, pp. 803–810, 2006
  16. Vascular Endothelial Growth Factor Overexpression by Soft Tissue Sarcoma Cells: Implications for Tumor Growth, Metastasis, and Chemoresistance
    Cancer Research, vol. 66, no. 17, pp. 8770–8778, 2006
  17. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor
    Cancer, vol. 107, no. 8, pp. 1898–1908, 2006
  18. Results of a Single-Center Experience With Resection and Ablation for Sarcoma Metastatic to the Liver
    Archives of Surgery, vol. 141, no. 6, pp. 537–544, 2006
  19. Extremity soft tissue sarcoma: Evidence-based multidisciplinary management
    Journal of Surgical Oncology, vol. 90, no. 1, pp. 10–13, 2005
  20. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma
    Cancer, vol. 103, no. 4, pp. 830–838, 2005
  21. Angiosarcoma of the breast
    Cancer, vol. 104, no. 12, pp. 2682–2688, 2005
  22. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome
    Human Molecular Genetics, vol. 14, no. 13, pp. 1785–1794, 2005
  23. Bilateral metastatic renal synovial sarcoma
    Urology, vol. 65, no. 2, pp. 389–389, 2005
  24. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo
    Molecular Cancer Therapeutics, vol. 4, no. 11, pp. 1710–1716, 2005
  25. A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors
    Cancer Research, vol. 64, no. 17, pp. 5913–5919, 2004
  26. Phase I Trial of Preoperative Doxorubicin-Based Concurrent Chemoradiation and Surgical Resection for Localized Extremity and Body Wall Soft Tissue Sarcomas
    Journal of Clinical Oncology, vol. 22, no. 16, pp. 3375–3380, 2004
  27. Upper Extremity Reconstruction Following Resection of Soft Tissue Sarcomas: A Functional Outcomes Analysis
    Annals of Surgical Oncology, vol. 11, no. 10, pp. 921–927, 2004
  28. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers
    Journal of Thoracic and Cardiovascular Surgery, vol. 127, no. 5, pp. 1366–1372, 2004
  29. Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
    Annals of Surgery, vol. 239, no. 6, pp. 818–827, 2004
  30. The Impact of Chemotherapy on the Survival of Patients With High-grade Primary Extremity Liposarcoma
    Transactions of the ... Meeting of the American Surgical Association, vol. CXXII, no. &NA;, pp. 284–295, 2004
  31. Platelet Kinetics and Decreased Transfusion Requirements After Splenectomy for Hematologic Malignancy
    Annals of Surgery, vol. 240, no. 5, pp. 852–857, 2004
  32. Transcriptional Repression of Protein Kinase C  via Sp1 by Wild Type p53 Is Involved in Inhibition of Multidrug Resistance 1 P-Glycoprotein Phosphorylation
    Journal of Biological Chemistry, vol. 280, no. 6, pp. 4825–4833, 2004
  33. A brief note about a new series!
    Cancer, vol. 100, no. 10, pp. 2047–2047, 2004
  34. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy
    Cancer, vol. 97, no. 10, pp. 2530–2543, 2003
  35. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy
    Cancer, vol. 97, no. 10, pp. 2544–2553, 2003
  36. Message from the editor
    Cancer, vol. 98, no. 1, pp. 1–1, 2003
  37. Emerging perspectives in soft tissue sarcoma
    Surgical Oncology Clinics of North America, vol. 12, no. 2, pp. xiii–xiv, 2003
  38. Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
    The American Journal of Surgery, vol. 186, no. 6, pp. 665–669, 2003
  39. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: A retrospective comparative evaluation of disease outcome
    International Journal of Radiation Oncology*Biology*Physics, vol. 56, no. 2, pp. 482–488, 2003
  40. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: Analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy
    International Journal of Radiation Oncology*Biology*Physics, vol. 57, no. 3, pp. 739–747, 2003
  41. Annals of Surgical Oncology Impact Factor/Rating Has Dramatically Increased
    Annals of Surgical Oncology, vol. 10, no. 1, pp. 1–3, 2003
  42. Phase I Trial of Preoperative Concurrent Doxorubicin and Radiation Therapy, Surgical Resection, and Intraoperative Electron-Beam Radiation Therapy for Patients With Localized Retroperitoneal Sarcoma
    Journal of Clinical Oncology, vol. 21, no. 16, pp. 3092–3097, 2003
  43. Extraosseous Osteosarcoma: Response to Treatment and Long-Term Outcome
    Journal of Clinical Oncology, vol. 20, no. 2, pp. 521–527, 2002
  44. Predictors of Locoregional Recurrence Among Patients With Early-Stage Breast Cancer Treated With Breast-Conserving Therapy
    Annals of Surgical Oncology, vol. 9, no. 3, pp. 256–265, 2002
  45. Long-Term Complications Associated With Breast-Conservation Surgery and Radiotherapy
    Annals of Surgical Oncology, vol. 9, no. 6, pp. 543–549, 2002
  46. Treatment and outcome of patients with intracystic papillary carcinoma of the breast
    The American Journal of Surgery, vol. 184, no. 4, pp. 364–368, 2002
  47. Steps toward mapping the human vasculature by phage display
    Nature Medicine, vol. 8, no. 2, pp. 121–127, 2002
  48. Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites
    BMJ, vol. 324, no. 7337, pp. 577–581, 2002
  49. Annals of Surgery, vol. 235, no. 5, pp. 722–731, 2002
  50. Soft tissue sarcoma of the upper extremity
    Cancer, vol. 94, no. 8, pp. 2256–2264, 2002
  51. Tumor specific gene expression profiles in human leiomyosarcoma
    Cancer, vol. 94, no. 7, pp. 2069–2075, 2002
  52. Tumor volume as a prognostic factor for sarcomatosis
    Cancer, vol. 94, no. 9, pp. 2441–2446, 2002
  53. Surgical management of soft tissue sarcomas of the hand and foot
    Cancer, vol. 95, no. 4, pp. 852–861, 2002
  54. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas
    Cancer, vol. 95, no. 5, pp. 1120–1126, 2002
  55. Characterization of 11 human sarcoma cell strains
    Cancer, vol. 95, no. 7, pp. 1569–1576, 2002
  56. Increasing the pool of academically oriented African-American medical and surgical oncologists
    Cancer, vol. 97, no. S1, pp. 329–334, 2002
  57. Alveolar soft part sarcoma
    Cancer, vol. 91, no. 3, pp. 585–591, 2001
  58. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas
    Cancer, vol. 92, no. 4, pp. 863–868, 2001
  59. Wild typep53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression
    Cancer, vol. 92, no. 6, pp. 1556–1566, 2001
  60. Note from the Editor-in-Chief
    Cancer, vol. 92, no. 9, pp. 2235–2236, 2001
  61. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas
    Cancer, vol. 94, no. 1, pp. 197–204, 2001
  62. The role of the surgical oncologist in multidisciplinary reearch (NOTE)
    Biomedecine & Pharmacotherapy, vol. 55, no. 9-10, p. 515, 2001
  63. Epithelioid sarcoma: results of conservative surgery and radiotherapy
    International Journal of Radiation Oncology*Biology*Physics, vol. 51, no. 2, pp. 384–391, 2001
  64. Primary treatment of cystosarcoma phyllodes of the breast
    Cancer, vol. 89, no. 7, pp. 1502–1511, 2000
  65. Prognostic Implications of Pathological Lymph Node Status After Preoperative Chemotherapy for Operable T3N0M0 Breast Cancer
    Annals of Surgical Oncology, vol. 7, no. 6, pp. 435–440, 2000
  66. Ductal Carcinoma-In-Situ: Long-Term Results of Breast-Conserving Therapy
    Annals of Surgical Oncology, vol. 7, no. 9, pp. 656–664, 2000
  67. Training for Careers in Academic Surgical Oncology: The Future Is Bright
    Annals of Surgical Oncology, vol. 6, no. 6, pp. 517–518, 1999
  68. Patterns of recurrence in extremity liposarcoma
    Cancer, vol. 85, no. 1, pp. 85–92, 1999
  69. Soft Tissue Sarcoma
    Seminars in Surgical Oncology, vol. 17, no. 1, pp. 1–1, 1999
  70. Inhibition of the transcription factor nuclear factor-?B by adenoviral-mediated expression of I?BaM results in tumor cell death
    Surgery, vol. 126, no. 2, pp. 399–405, 1999
  71. Role of radiotherapy in sarcoma of the breast – a retrospective review of the M.D. Anderson experience
    Radiotherapy and Oncology, vol. 52, no. 2, pp. 173–178, 1999
  72. Resectable recurrent extremity sarcomas: is there a role for re-irradiation?
    Surgical Oncology, vol. 8, no. 4, pp. 219–221, 1999
  73. Staging and prognostic factors in soft tissue sarcoma
    Seminars in Radiation Oncology, vol. 9, no. 4, pp. 307–314, 1999
  74. Laparoscopic splenectomy in patients with hematologic malignancies
    The American Journal of Surgery, vol. 178, no. 6, pp. 530–535, 1999
  75. Reliable establishment of human sarcoma xenografts in the nude rat
    Sarcoma, vol. 3, no. 2, pp. 129–133, 1999
  76. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro
    Melanoma Research, vol. 8, no. 3, pp. 227–239, 1998
  77. Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection
    The American Journal of Surgery, vol. 176, no. 3, pp. 239–243, 1998
  78. Locally recurrent soft tissue sarcoma of the extremities?, ??
    Surgery, vol. 123, no. 6, pp. 666–671, 1998
  79. Hemangiopericytoma: A 20-year single-institution experience
    Annals of Surgical Oncology, vol. 5, no. 4, pp. 350–355, 1998
  80. Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: A single-institution, 25-year experience*1
    Surgery, vol. 122, no. 1, pp. 20–25, 1997
  81. Lower Extremity Salvage After Radical Resection of Malignant Tumors in the Groin and Lower Abdominal Wall
    Journal of the American College of Surgeons, vol. 185, no. 3, pp. 260–267, 1997
  82. Role of Splenectomy in Chronic Lymphocytic Leukemia
    Journal of the American College of Surgeons, vol. 185, no. 3, pp. 237–243, 1997
  83. Enhanced MDM2 oncoprotein expression in soft tissue sarcoma: several possible regulatory mechanisms
    Sarcoma, vol. 1, no. 1, pp. 23–30, 1997
  84. Malignant fibrous histiocytoma in children*1
    Journal of Pediatric Surgery, vol. 31, no. 8, pp. 1080–1083, 1996
  85. The National Cancer Data Base report on soft tissue sarcoma
    Cancer, vol. 78, no. 10, pp. 2247–2257, 1996
  86. Ethics of Research Training for NIH T32 Surgical Investigators
    Journal of Surgical Research, vol. 58, no. 2, pp. 247–251, 1995
  87. Soft-Tissue sarcomas of the shoulder girdle: Factors influencing local recurrence, distant metastases, and survival
    Annals of Surgical Oncology, vol. 2, no. 6, pp. 530–536, 1995
  88. Human peri-tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains
    International Journal of Cancer, vol. 62, no. 5, pp. 585–592, 1995
  89. Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy*
    Surgery, vol. 118, no. 2, pp. 237–244, 1995
  90. Computer simulations and management of critical incidents
    Academic Medicine, vol. 69, no. 3, p. 213, 1994
  91. Risk of Dissemination of Cancer to Flap Donor Sites During Immediate Reconstructive Surgery
    Annals of Plastic Surgery, vol. 33, no. 6, pp. 573–575, 1994
  92. Molecular determinants of soft tissue sarcoma proliferation
    Seminars in Surgical Oncology, vol. 10, no. 5, pp. 315–322, 1994
  93. Diagnosing intramuscular myxoma by fine-needle aspiration: A multidisciplinary approach
    Diagnostic Cytopathology, vol. 11, no. 3, pp. 255–261, 1994
  94. What is a surgical oncologist?
    Annals of Surgical Oncology, vol. 1, no. 1, pp. 2–4, 1994
  95. Immediate versus delayed free-tissue transfer salvage of the lower extremity in soft tissue sarcoma patients
    Annals of Surgical Oncology, vol. 1, no. 1, pp. 11–17, 1994
  96. Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation
    Annals of Surgical Oncology, vol. 1, no. 5, pp. 415–422, 1994
  97. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas
    Cancer, vol. 73, no. 6, pp. 1652–1659, 1994